MoU to strengthen biomedical science partnership
The Australian Institute of Medical Scientists (AIMS) and the UK Institute of Biomedical Science (IBMS) have signed a memorandum of understanding that is intended to strengthen the partnership between the two organisations for the benefit of members, the global biomedical science community and the profession.
AIMS President Robyn Wells and IBMS President Ian Sturdgess said in a joint statement that the agreement “follows a successful meeting in London that is the forerunner for closer ties and collaboration”.
According to AIMS CEO Edward Fraser, the vision of the agreement is to strengthen the profession in two leading nations in the medical science field and ensure global cross-fertilisation of ideas to improve health outcomes. As such, the agreement highlights a number of exciting areas for exploration, including membership, qualifications and the sharing of good practice guidance.
“The partnership with AIMS will ensure that the reach and relevance of biomedical science is felt beyond the two organisations and will facilitate recognition for laboratory professionals globally,” noted IBMS CEO Jill Rodney.
TGA approves donanemab for treatment of early Alzheimer's
The TGA has approved the first amyloid-targeting therapy for people with Alzheimer's in...
Ultra-processed foods linked to poor health, premature death
Evidence suggests a dose-response relationship between ultra-processed food consumption and...
Shorter radiotherapy course proves safe for prostate cancer
A significantly shorter course of radiotherapy for localised prostate cancer is just as safe and...
